CardiacWire
SEPTEMBER 22, 2024
Edgewise tested EDG-7500 in a Phase 1 trial to confirm the drug’s side effects, and an early part of a Phase 2 trial to measure EDG-7500’s impact on key oHCM biomarkers – and both trials proved successful. The EDG-7500 groups also had no meaningful changes in LVEF, and none of the subjects experienced a decrease in LVEF <50%.
DAIC
DECEMBER 22, 2023
By coupling machine learning methods with the company’s VECG technology, HeartBeam aims to provide physicians with unprecedented diagnostic and prognostic insights about cardiac health that it believes will exceed the information provided by a standard 12-lead electrocardiogram (ECG).
Dr. Smith's ECG Blog
SEPTEMBER 26, 2023
The primary endpoint was the association of pre-hospital initial chest pain severity, cardiac biomarkers and infarct size based on cardiac magnetic resonance imaging. Groups were categorized based on moderate to severe chest pain (numerical rating scale pain ≥ 5/10) or less than moderate severity to compare procedural and clinical outcomes.
The British Journal of Cardiology
JUNE 11, 2024
Cardiovascular consultation had been requested for all of the patients based on their primary clinical examination, vital signs, and electrocardiogram (ECG). Additionally, 2D transthoracic echocardiography (TTE), and myocardial injury serum biomarkers assays (creatine phosphokinase-MB [CPK-MB] and cardiac troponins [cTn]) were measured once.
Dr. Smith's ECG Blog
DECEMBER 22, 2023
The patient with no prior cardiac history presented in the middle of the night with acute chest pain, and had this ECG recorded during active pain: I did not see any ischemia on this electrocardiogram. The ESC states that patients with suspected ACS should go to the cath lab in ＜2 hours "regardless of ECG or biomarker evidence of MI!!"
Dr. Smith's ECG Blog
APRIL 18, 2024
1] European guidelines add "regardless of biomarkers". International evaluation of an artificial-intelligence- powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. But only 6.4% of such ‘high risk Non-STEMI’ patients get angiography within 2 hours.[2] Clin Cardiol 2022 4. McLaren and Smith.
GEMMS
MAY 22, 2024
Traditional tools like stethoscopes, blood pressure gauges, and electrocardiograms (ECG) are fundamental for standard diagnostic practices. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.
Expert insights. Personalized for you.
105 
Let's personalize your content